15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer

Thorax

Volumn 65, Issue 4, 2010, Pages 321-326

  Yuan, Huiling ^a   Li, Ming Yue ^a   Ma, Lily T ^a   Hsin, Michael K Y ^a   Mok, Tony S K ^a   Underwood, Malcolm J ^a   Chen, George G ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ARACHIDONATE 15 LIPOXYGENASE; HYDROXY FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; TISSUE LEVEL;

EID: 77950910962     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.122747     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Spira A, Ettinger DS. Extensive-stage small-cell lung cancer. Semin Surg Oncol 2003;21:164-175
3. Keshamouni VG, Reddy RC, Arenberg DA, et al. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. Oncogene 2004;23:100-108
4. Sarraf P, Mueller E, Jones D, et al. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 1998;4:1046-1052 (Pubitemid 28417337)
5. Satoh T, Toyoda M, Hoshino H, et al. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene 2002;21:2171-2180 (Pubitemid 34311371)
6. Li MY, Lee TW, Yim AP, et al. Function of PPARgamma and its ligands in lung cancer. Crit Rev Clin Lab Sci 2006;43:183-202. (Pubitemid 43860450)
7. Theocharis S, Kanelli H, Politi E, et al. Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade. Lung Cancer 2002;36:249-255 (Pubitemid 34497122)
8. Shureiqi I, Wojno KJ, Poore JA, et al. Decreased 13-S- hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 1999;20:1985-1995 (Pubitemid 29476127)
9. Shankaranarayanan P, Nigam S. IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15- hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor. J Immunol 2003;170:887-894 (Pubitemid 36070542)
10. Yang Q, Feng Y, Schultz CJ, et al. Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer. Cancer Gene Ther 2008;15:323-330 (Pubitemid 351508139)
11. Chen GG, Xu H, Lee JF, et al. 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int J Cancer 2003;107:837-843 (Pubitemid 37339740)
12. Kalscheuer S, Zhang X, Zeng Y, et al. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone. Carcinogenesis 2008;29:2394-2399
13. Li M, Lee TW, Yim AP, et al. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. J Cell Physiol 2006;209:428-438 (Pubitemid 44484634)
14. Li M, Lee TW, Mok TS, et al. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. J Cell Biochem 2005;96:760-774 (Pubitemid 41567547)
15. Chen GG, Lee TW, Xu H, et al. Increased inducible nitric oxide synthase in lung carcinoma of smokers. Cancer 2008;112:372-381
16. Heslin MJ, Hawkins A, Boedefeld W, et al. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Ann Surg 2005;241:941-946 (Pubitemid 40733969)
17. Hennig R, Kehl T, Noor S, et al. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia 2007;9:917-926 (Pubitemid 350086437)
18. Wu Y, Fang B, Yang XQ, et al. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther 2008;16:886-892 (Pubitemid 351587098)
19. Wang D, Chen S, Feng Y, et al. Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas. Tumour Biol 2006;27:261-273 (Pubitemid 44260251)
20. Xu XC, Shappell SB, Liang Z, et al. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia 2003;5:121-127
21. Bhatia B, Maldonado CJ, Tang S, et al. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem 2003;278:25091-25100 (Pubitemid 37548673)
22. Gonzalez AL, Roberts RL, Massion PP, et al. 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Hum Pathol 2004;35:840-849
23. His LC, Xi X, Wu Y, et al. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther 2005;4:1740-1746
24. Shureiqi I, Wu Y, Chen D, et al. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res 2005;65:11486-11492
25. Shappell SB, Keeney DS, Zhang J, et al. 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa. J Invest Dermatol 2001;117:36-43.
26. Shappell SB, Gupta RA, Manning S, et al. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 2001;61:497-503.
27. Subbarayan V, Xu XC, Kim J, et al. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia 2005;7:280-293
28. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-469
29. Belinsky SA, Devereux TR, Foley JF, et al. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 1992;52:3164-3173
30. Tang DG, Bhatia B, Tang S, et al. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins Other Lipid Mediat 2007;82:135-146
31. Kuhn H, Borngraber S. Mammalian 15-lipoxygenases. Enzymatic properties and biological implications. Adv Exp Med Biol 1999;447:5-28.
32. Needleman P, Turk J, Jakschik BA, et al. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
33. Seiler A, Schneider M, Forster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 2008;8:237-248